LNTH Stock Price Chart
LNTH Earnings
Lantheus Holdings Inc
$84.11
-0.26%
$-0.21
At close: Apr 27, 16:00:00 GMT-4
$83.27
-0.99%
$-0.84
Pre-market: Apr 28, 09:33:10 GMT-4
Back
Lantheus Holdings Inc (LNTH) Earnings
Latest Earnings Results: Q4 '25
Reported: 2026-02-26
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did LNTH's recent EPS compare to expectations?
How did Lantheus Holdings Inc LNTH's revenue perform in the last quarter?
What is the revenue estimate for Lantheus Holdings Inc?
What's the earning quality score for Lantheus Holdings Inc?
When does Lantheus Holdings Inc report earnings?
What are Lantheus Holdings Inc's expected earnings?
Did Lantheus Holdings Inc beat earnings expectations?
Key Stats
Prev.Close
$84.33
Open
$84.33
Day's Range
$83.27 - $85.26
52 week range
$47.25 - $108.91
Volume
629.4K
Avg.Volume
939.9K
Dividend yield
--
EPS (TTM)
3.36
Market Cap
$5.4B
What is LNTH?
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 1,193 full-time employees. The company went IPO on 2015-06-25. The firm's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The firm's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The firm's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The firm's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.
Features
Resources
© 2026 Finture Development Limited. All rights reserved